References
Adler DG, Baron TH, Davila RE, et al; Standards of Practice Committee of American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005; 62(1):1-8
2. Badalov N, Tenner S, Baillie J. The prevention, recognition and treatment of post- ERCP pancreatitis. JOP 2009; 10(2):88-97.
3. Dumonceau JM, Andriulli A, Deviere J, et al; European Society of Gastrointestinal Endoscopy. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010; 42(6):503-515.
4. Jeurnink SM, Siersema PD, Steyerberg EW, et al. Predictors of complications alter endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge. Surg Endosc 2011; 25(9):2892-2900.
5. Testoni PA, Giussani A, Vailati C, et al. Precut sphincterotomy, repeated cannulation and post-ERCP pancreatitis in patients with bile duct stone disease. Dig Liver Dis 2011; 43(10):792-796.
6. Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010; 42(10):842-853.
7. Pahk A, Rigaux J, Poreddy V, et al. Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate. Dig Dis Sci 2011; 56(10):3058-3064.
8. Cennamo V, Fuccio L, Zagari RM, et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy 2010; 42(5):381-388
9. Nakai Y, Isayama H, Sasahira N, et al. Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP. Gastrointest Endosc. 2015;81(1):119-26
10. Elmunzer BJ, Scheiman JM, Lehman GA, et al; U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012; 366(15):1414-1422.
11. Ito K, Fujita N, Noda Y, et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. J Gastroenterol 2010; 45(11):1183-1191.
12. Fazel A, Quadri A, Catalano MF, et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endoscop 2003; 57(3):291-294.
13. Deviere J. Pancreatic stents. Gastrointest EndoscClin N Am 2011; 21(3):499-510.
14. Elmi F., Rossi F., Lim J.K., et al. A prospective, multicenter, randomized, double-blinded controlled study to determine wether a single dose of intraduodenal indomethacincan decrease the incidente and severity of post-ERCP pancreatitis. Gastrointest Endosc 2010; 71:5 (AB232).
15. Sofuni A, Maguchi H, Mukai T, et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol 2011; 9(10):851-858.
16. Dumonceau JM, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline updated June 2014. Endoscopy. 2014;46(9):799-815